pre-miRNA Information | |
---|---|
pre-miRNA | hsa-let-7a-1 |
Genomic Coordinates | chr9: 94175957 - 94176036 |
Synonyms | LET7A1, MIRNLET7A1, let-7a-1, MIRLET7A1 |
Description | Homo sapiens let-7a-1 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-let-7a-3 |
Genomic Coordinates | chr22: 46112749 - 46112822 |
Synonyms | LET7A3, MIRNLET7A3, let-7a-3, MIRLET7A3 |
Description | Homo sapiens let-7a-3 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-let-7a-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 57| CUAUACAAUCUACUGUCUUUC |77 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TP53INP1 | ||||||||||||||||||||
Synonyms | SIP, TP53DINP1, TP53INP1A, TP53INP1B, Teap, p53DINP1 | ||||||||||||||||||||
Description | tumor protein p53 inducible nuclear protein 1 | ||||||||||||||||||||
Transcript | NM_001135733 | ||||||||||||||||||||
Other Transcripts | NM_033285 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TP53INP1 | |||||||||||||||||||||
3'UTR of TP53INP1 (miRNA target sites are highlighted) |
>TP53INP1|NM_001135733|3'UTR 1 GACTCACGGGCACAGAAGTGGAAGCTCAAAATGAAATGGGGCAGCATATTCATTGTTATGTTGCAGCTCTTGCTGCTCAT 81 ACAACTTTTCTGGAACAACCCAAGAGCTTTCGCCCTTCCCAGTGGATAAAAGAACACAGTGAAAGACAGCCTCTTAACAG 161 AAATAGCCTTCGTCGCCAAAATCTTACCAGGGATTGCCACCCTCGGCAAGTCAAGCACAATGGCTGGGTTGTTCATCAGC 241 CCTGCCCGCGTCAGTACAATTACTAATAGTTTCAAGTTTTGTTGGTTGGTTTCTCTTGGTTTGTGCTTACATGTATGGAT 321 GTGTGTATATGTACAGTGAAAATGTTGTCTCTTTACAACCAATTGATAACCAATCACATAGTTTTATCAGTGTATTTAGA 401 CACTATCTTGAAAATCAGATTTATATGCTGTGTATCACATAATGCCTTGCCTTTAACATTTACTTTTTTTGTACACTTTT 481 TCAGATTATTTCTGGAAACATATCAATATAATTACAGTGTTTGGGGGTGTCTTTAAATATATTAGGTTATACATTAGTCA 561 GCATTTTAAAGACATTTCTTCCCAAGTACGAGAATAGGCATCTTTCATTTTCATTTTATTTTGTATTACTTAATCTTTTA 641 AGCAAGCAAAAATTTATTCTCAGGGTCAGCTGTACACTTTATTGACCAGTACTTGATAATCTCTCTGTATATGATGAATA 721 CATTTTTACACACTAACATTAGCATTAACAGGTGATAGTTGCCATGGATATAATGGAATTATGGCTGGACTTTCTTTTGA 801 AAGAAAACTTGATGTATTCTGTGTGTATGGTTTTTCCCCAGATTAGTCATACAGTTCATTTGGAATTCAGGTACATTAAG 881 CTTTAGTGAAGAGTGCATGCAGTAATTCCAATGTGACTGCATGACGTGGTACAGACATTACAGGTGTTGTAGACAGAGGC 961 ACTTGTCTCGTGCAGAGGGATTAAATTAGACCTGTGAGATTATATTTGGAAAAATTCATGTCTGTAACTAACCCATTAGT 1041 GCAGTATTTAATTTGTTACTATTCCTTCCCGCCAATTCTGTCCACTCCTCACCTCGCATCAGCTATAAATTTGGAAGTAC 1121 TTGTCCAGGCACTCAAGTGACTTCATATTTCTCTCTGCCCATGGGAAAAGAGATAGGCTTTATATTTCCACAGAGTGAAA 1201 AATCCTCTGTCATGGAGCCTGTCCTGCCAAGTGGCAAGAGTGTGGGGACTGTCTGGTGATGATGTCTTTCATGGCATCTG 1281 AGTGAAGAGTGACAGGTTGGCTCAACTTTTTTCTTTTTTTTTTTTTAATTGCCTTGTATTGTAAGTATTCTTCCCTGCAG 1361 TCCAAGTGACTTTTCATTTTTTGTTTTAACTTCAGGCAAAATCTTTAACCACTCTGGCCTCTGTTTCCCCCACCAACGGG 1441 GAGCAGTGACATTTACCTCCCTCACAGAGTCACTGTGAGGATTCTATACTGATTTGAAGTGGAGCTGTTCAGAACTGAAC 1521 CTTGTAGGAAATTCCAAGGGCCTTTCTACTGAATCTGGTGATGGGGTGGGGCCGTGGCACTTTCTCTGCCACAGCTGTTC 1601 TTCACAGTGTTGGTGCTAATGAGGCCAGGGTGCAGGGTTCGATTCACACGTAGGCCAGTTAACTTAGAGAAAATCTATTT 1681 CCTTACCTCTAGCCAGTCACTTCCTTTTTCCGCAGTTGTGATGGGTTTTGCTGAGCCATCCACTCTGACTGATTTCCTCT 1761 GAAGTAAACATATTTACAATCCAAAGCAATTCTACTGACAGAAGTGTTGCCTTCATAATCAAACAGCTTGTTTTTCCATC 1841 TCCTCTGCAACCCTAATTAAATGAGTACAGGTCTACAAAATGTTTTCAAGGAGAAAAGCAGCATATCCTTAAGTGAAGTA 1921 TTATATTTTTCAATAACCCTGTAGTGGCTTGATGCAGGGAACCCTGGGGGACTTTCAGCGAAGAGCTGTGCTCTTTTCTG 2001 ACTAGATTAGAGCGTTTGGAGTGGAAGACGTCAAATGTGTAGTGAGATGGAGGTTTTACATTGTTCTTCTACTGGCTGTG 2081 ATGAAGTGCCAGAATGTCTCTTTAGAACAAGAGTTAGATTCCCCCTTTCTCCTTATTGCCCCTTCCGTTTTGACTTCCCC 2161 TTTATTTATTTGTTGTCTAATTAGGGGCCAAGTCTGTAAAGTTTTGTCAAAGTGAGTTAGAAGTTGTTTTCTCTTACTAT 2241 TTGTGTTTACCAGAGTTGGGAGATAAGATAGTTTCCATGAAGGTGTGTATGTTTTATACGATGTTTGTTATAGGGCCATG 2321 CATTGGTAACTTGAAAATAGACCAGCTTAATGTCTTCAGGATGTAAAACTCTGAATACACGGCGTCTCTTTTTCATACAT 2401 TGCATGTAAGTTGTTAGTACCTCACAAGCTACAGAAGTTCAGCCATGAGATTTTGTTTGGCAACATGAACAGATTTGTGT 2481 ATAACTGCAATGGCCTTTTTTTCCAGATTTCCTTATTGACTTTTTGTTTGCCTTACCTGGGGCTAGTTTTTTATGCTTTG 2561 TACCTAGAAAACAAAAAATTACATTCGTTGGGCTTTTTTTCAAGGTTGGGATTACCACACCACCTGGAATATCATACTGT 2641 GGTTTCTGCCTAAAATTGGCACATGTAAGTATTGAAGAAAATGGTTATATAATTCAGTTGAAACTCTTGGTTATTAGATG 2721 TTAGGCATCTCCTGTATGTAAGACACAAGGCCAACCACAACACAGAACGATGTTGACCTGTTAAGTATTCTCTGAAACAT 2801 GGCCAAAATGCATTTTATGAGCTTTTTTTTTTGCTATTGTAAATATTAGTGGTTTACAATGCGCTTTAGACATATTTCTT 2881 TAAAATGCAAGCAGTGAGAAATAAGACCTCTCTGAATTAGTAGCTCTAAACTGTTAACATAGAATGTTACTTGGAAAAAG 2961 TCTGGAATATGTGGTGTACACAAGCAGTGCTTCGTGAATGAGTTTCTTAGCTTTTATAGTGCGCCATGTTTCTCAAAGTT 3041 TGTTTTTGTTGACAAAACATTTTATAATATATATCTTATGTTTATTTTTTTTCTCAACTAATTGTGTACTGCACTGTAAG 3121 GTGAAAATTAGCCATCCATTATTTATCTTCTGTGGCAATGCATTTATATGGTTGATTGGGTGGGGAATTTTTTGCAGAAA 3201 GATGCAAAGTGATTGGGTTTTCGACTTCCTATCGCAGGGAGCTTTTAAGAAATATTAATTTCCTATACATTTTTCCAATC 3281 CCCATGCAAACTGTTCCTGTTTACATACCTTCTCTGTTGTATCAGTACTTTGAGTGAGAAGACAGTTTATTTAAAACTTG 3361 AGCAGGCTGTTCAGCATTGTTTCTGCTTCTGAAATCTGTATAGTACACTGGTTTGTAATCATTATGTCTTCATTGAAATC 3441 CTTGCTACTTCTCTTCCTCCTCAATGAAATACATTATATATTATCTTTATGTACTCTTAAGAAAAACGAGCAAGGAAGAG 3521 TATCTTCATTATTCTCATTTTCTCTGAGTTGGAAACAAAAACATGAAGGACTCCAACTAGAAGACAGATATTTACATTTA 3601 AATAGATTAGTGGGAAAACTTTAAGAGTTTCCACATATTAGTTTTCATTTTTTGAGTCAAGAGACTGCTCCTTGTACTGG 3681 GAGACACTAGTAGTATATGTTTGTAATGTTACTTTAAAATTATCTTTTTATTTTATAAGGCCCATAAATACTGGTTAAAC 3761 TCTGTTAAAAGTGGGCCTTCTATCTTGGATGGTTTCACTGCCATCAGCCATGCTGATATATTAGAAATGGCATCCCTATC 3841 TACTTACTTTAATGCTTAAAATTATACATAAAATGCTTTATTTAGAAAACCTACATGATACAGTGGTGTCAGCCTTGCCA 3921 TGTATCAGTTTCACTTGAAATTTGAGACCAATTAAATTTCAACTGTTTAGGGTGGAGAAAGAGGTACTGGAAAACATGCA 4001 GATGAGGATATCTTTTATGTGCAACAGTATCCTTTGCATGGGAGGAGAGTTACTCTTGAAAGGCAGGCAGCTTAAGTGGA 4081 CAATGTTTTGTATATAGTTGAGAATTTTACGACACTTTTAAAAATTGTGTAATTGTTAAATGTCCAGTTTTGCTCTGTTT 4161 TGCCTGAAGTTTTAGTATTTGTTTTCTAGGTGGACCTCTGAAAACCAAACCAGTACCTGGGGAGGTTAGATGTGTGTTTC 4241 AGGCTTGGAGTGTATGAGTGGTTTTGCTTGTATTTTCCTCCAGAGATTTTGAACTTTAATAATTGCGTGTGTTTTTTTTT 4321 TTTTTAAGTGGCTTTGTTTTTTTTTCTCAAGTAAAATTGTGAACATATTTCCTTTATAGGGGCAGGGCATGAGTTAGGGA 4401 GACTGAAGAGTATTGTAGACTGTACATGTGCCTTCTTAATGTGTTTCTCGACACATTTTTTTTCAGTAACTTGAAAATTC 4481 AAAAGGGACATTTGGTTAGGTTACTGTACATCAATCTATGCATAAATGGCAGCTTGTTTTCTTGAGCCACGGTCTAAATT 4561 TTGTTTTTATAGAAATTTTTTATACTGATTGGTTCATAGATGGTCAGTTTTGTACACAGACTGAACAATACAGCACTTTG 4641 CCAAAAATGAGTGTAGCATTGTTTAAACATTGTGTGTTAACACCTGTTCTTTGTAATTGGGTTGTGGTGCATTTTGCACT 4721 ACCTGGAGTTACAGTTTTCAATCTGTCAGTAAATAAAGTGTCCTTTAACTTCAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 94241.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000448464.2 | 3UTR | CAUGAACAGAUUUGUGUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-let-7a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038998 | ARMC8 | armadillo repeat containing 8 | 1 | 1 | ||||||||
MIRT038999 | SETD4 | SET domain containing 4 | 1 | 1 | ||||||||
MIRT039000 | BTF3 | basic transcription factor 3 | 1 | 1 | ||||||||
MIRT039001 | MIPOL1 | mirror-image polydactyly 1 | 1 | 1 | ||||||||
MIRT039002 | TRIM33 | tripartite motif containing 33 | 1 | 1 | ||||||||
MIRT039003 | CS | citrate synthase | 1 | 1 | ||||||||
MIRT039004 | SENP7 | SUMO1/sentrin specific peptidase 7 | 1 | 1 | ||||||||
MIRT055418 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 10 | ||||||||
MIRT057681 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 8 | ||||||||
MIRT061351 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT062174 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT071813 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT091374 | EIF4A2 | eukaryotic translation initiation factor 4A2 | 2 | 2 | ||||||||
MIRT095107 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT098814 | PPIL4 | peptidylprolyl isomerase like 4 | 2 | 2 | ||||||||
MIRT109534 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT120263 | GSK3B | glycogen synthase kinase 3 beta | 2 | 2 | ||||||||
MIRT149839 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT164519 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT165879 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT169899 | HBP1 | HMG-box transcription factor 1 | 2 | 4 | ||||||||
MIRT182779 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT193466 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT226421 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 2 | ||||||||
MIRT334410 | CREBZF | CREB/ATF bZIP transcription factor | 2 | 6 | ||||||||
MIRT338286 | SYF2 | SYF2 pre-mRNA splicing factor | 2 | 2 | ||||||||
MIRT361627 | TES | testin LIM domain protein | 2 | 2 | ||||||||
MIRT406687 | ZNF181 | zinc finger protein 181 | 2 | 2 | ||||||||
MIRT407768 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT449468 | HAT1 | histone acetyltransferase 1 | 2 | 2 | ||||||||
MIRT467110 | SRI | sorcin | 2 | 2 | ||||||||
MIRT475099 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 2 | 6 | ||||||||
MIRT481671 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT493061 | MTFR1 | mitochondrial fission regulator 1 | 2 | 2 | ||||||||
MIRT497923 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498202 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT503391 | ASB11 | ankyrin repeat and SOCS box containing 11 | 2 | 6 | ||||||||
MIRT503862 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT504368 | ARID1B | AT-rich interaction domain 1B | 2 | 4 | ||||||||
MIRT504991 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT505754 | SENP1 | SUMO1/sentrin specific peptidase 1 | 2 | 8 | ||||||||
MIRT518102 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 2 | 6 | ||||||||
MIRT521930 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT522139 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT522401 | MYADM | myeloid associated differentiation marker | 2 | 4 | ||||||||
MIRT523593 | FZD5 | frizzled class receptor 5 | 2 | 4 | ||||||||
MIRT523944 | E2F8 | E2F transcription factor 8 | 2 | 4 | ||||||||
MIRT524355 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT525140 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT527070 | ABCC4 | ATP binding cassette subfamily C member 4 | 2 | 2 | ||||||||
MIRT527486 | OCIAD1 | OCIA domain containing 1 | 2 | 2 | ||||||||
MIRT528129 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 2 | 2 | ||||||||
MIRT530528 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | 2 | 2 | ||||||||
MIRT531270 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT538898 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT541371 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT541526 | MGAT4C | MGAT4 family member C | 2 | 2 | ||||||||
MIRT543776 | RBM12B | RNA binding motif protein 12B | 2 | 4 | ||||||||
MIRT543946 | NCOA7 | nuclear receptor coactivator 7 | 2 | 2 | ||||||||
MIRT545156 | GABRG1 | gamma-aminobutyric acid type A receptor gamma1 subunit | 2 | 2 | ||||||||
MIRT545848 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT546064 | VEZF1 | vascular endothelial zinc finger 1 | 2 | 2 | ||||||||
MIRT546481 | SLC16A14 | solute carrier family 16 member 14 | 2 | 4 | ||||||||
MIRT551835 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT551901 | ACP1 | acid phosphatase 1, soluble | 2 | 2 | ||||||||
MIRT552490 | ZNF136 | zinc finger protein 136 | 2 | 2 | ||||||||
MIRT554206 | SLC35A5 | solute carrier family 35 member A5 | 2 | 2 | ||||||||
MIRT554295 | SIPA1L2 | signal induced proliferation associated 1 like 2 | 2 | 2 | ||||||||
MIRT555765 | PCTP | phosphatidylcholine transfer protein | 2 | 2 | ||||||||
MIRT558315 | DSG2 | desmoglein 2 | 2 | 2 | ||||||||
MIRT563147 | NOLC1 | nucleolar and coiled-body phosphoprotein 1 | 2 | 2 | ||||||||
MIRT566464 | PGGT1B | protein geranylgeranyltransferase type I subunit beta | 2 | 2 | ||||||||
MIRT567322 | HMGB2 | high mobility group box 2 | 2 | 2 | ||||||||
MIRT567738 | DLX2 | distal-less homeobox 2 | 2 | 2 | ||||||||
MIRT567892 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT570087 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 2 | ||||||||
MIRT571136 | TTC33 | tetratricopeptide repeat domain 33 | 2 | 2 | ||||||||
MIRT573534 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT574465 | RPS16 | ribosomal protein S16 | 2 | 2 | ||||||||
MIRT574998 | Phka1 | phosphorylase kinase alpha 1 | 2 | 3 | ||||||||
MIRT610202 | CD99 | CD99 molecule (Xg blood group) | 2 | 4 | ||||||||
MIRT612926 | GPRIN3 | GPRIN family member 3 | 2 | 2 | ||||||||
MIRT615027 | DUSP6 | dual specificity phosphatase 6 | 2 | 2 | ||||||||
MIRT617200 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT628720 | ZNF585A | zinc finger protein 585A | 2 | 2 | ||||||||
MIRT641491 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT641663 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT642216 | RUVBL2 | RuvB like AAA ATPase 2 | 2 | 2 | ||||||||
MIRT654589 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT656136 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT656899 | KIAA2018 | upstream transcription factor family member 3 | 2 | 2 | ||||||||
MIRT660136 | BRPF3 | bromodomain and PHD finger containing 3 | 2 | 2 | ||||||||
MIRT660861 | AFAP1 | actin filament associated protein 1 | 2 | 2 | ||||||||
MIRT676849 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | 2 | 3 | ||||||||
MIRT681479 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT682259 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT685602 | MYOM2 | myomesin 2 | 2 | 2 | ||||||||
MIRT686943 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT694302 | COPB2 | coatomer protein complex subunit beta 2 | 2 | 2 | ||||||||
MIRT694407 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 | ||||||||
MIRT697280 | ZNF800 | zinc finger protein 800 | 2 | 2 | ||||||||
MIRT698414 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698989 | SPAG9 | sperm associated antigen 9 | 2 | 2 | ||||||||
MIRT699766 | SEMA4D | semaphorin 4D | 2 | 2 | ||||||||
MIRT699928 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT702113 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT702373 | KLF10 | Kruppel like factor 10 | 2 | 2 | ||||||||
MIRT702646 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT705713 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT717925 | ZNF546 | zinc finger protein 546 | 2 | 2 | ||||||||
MIRT720839 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT725033 | NDUFAF7 | NADH:ubiquinone oxidoreductase complex assembly factor 7 | 2 | 2 | ||||||||
MIRT731448 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | 1 | 1 | ||||||||
MIRT733217 | CCNG1 | cyclin G1 | 2 | 0 | ||||||||
MIRT734887 | LIN28B | lin-28 homolog B | 1 | 0 | ||||||||
MIRT735276 | HMGA2 | high mobility group AT-hook 2 | 2 | 0 | ||||||||
MIRT735727 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 3 | 0 | ||||||||
MIRT736087 | RCVRN | recoverin | 1 | 0 | ||||||||
MIRT736088 | RHO | rhodopsin | 1 | 0 | ||||||||
MIRT736103 | TLR7 | toll like receptor 7 | 1 | 0 | ||||||||
MIRT736607 | TPO | thyroid peroxidase | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|